Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126356441 | 12635644 | 1 | I | 20160801 | 20160809 | 20160809 | EXP | US-ASTRAZENECA-2016SE84751 | ASTRAZENECA | 0.00 | M | Y | 83.90000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126356441 | 12635644 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
| 126356441 | 12635644 | 2 | SS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 0 | 25 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 126356441 | 12635644 | 3 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 126356441 | 12635644 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126356441 | 12635644 | 1 | Blood cholesterol increased |
| 126356441 | 12635644 | 2 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126356441 | 12635644 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126356441 | 12635644 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126356441 | 12635644 | 1 | 2005 | 0 |